Search
for
Sort by
Research 61–90 of 1000+
- Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
- Epidemiology of alopecia areata in Hispanic/Latinx patients
- Use of Complementary Alternative Medicine and Supplementation for Skin Disease
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- The Immunological Association between Alopecia Areata and Respiratory Diseases: A Systematic Review
- Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database
- Successful Treatment of Multiple Alopecia Areata With Contact Immunotherapy: Supportive Usage of Oral Antihistamine and Topical Corticosteroid
- Associated comorbidities in pediatric patients with alopecia areata
- 724 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled study to evaluate the efficacy and safety of rezpegaldesleukin in adults with severe to very-severe alopecia areata
- Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
- PROFILE OF ALOPECIA AREATA: A QUESTIONNAIRE ANALYSIS OF PATIENT AND FAMILY
- Alopecia Areata in Korea (1982–1994)
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening
- Quality of life in patients with alopecia areata: a hospital‐based cross‐sectional study
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
- Late-Onset Alopecia Areata: A Retrospective Cohort Study
- Associations between season, climate, and pediatric alopecia areata flares in Providence, Rhode Island
- Friend or foe: A systematic review of dupilumab and alopecia areata
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Association Between Vitamin D and Zinc Levels With Alopecia Areata Phenotypes at a Tertiary Care Center
- Epidemiology of alopecia areata and population-wide comorbidities in Germany: analysis of longitudinal claims data
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- Patterns and predictors of Quality-of-Life impairment in alopecia areata: A cross-sectional analysis from south India
- Associated comorbidities in pediatric patients with alopecia areata
- Clinical and demographic factors associated with nail involvement in adult alopecia areata patients at Al-Kadhmia teaching hospital, Baghdad, 2023
- Approved systemic drugs needed for dermatosis like alopecia areata, hidradenitis and vitiligo: A SPIN‐FRT evaluation
- Comparative characteristics of the effectiveness of drugs for the treatment of alopecia areata in childhood